BEKE-W
02423
XIAOMI-W
01810
ALI HEALTH
00241
JD HEALTH
06618
MEITUAN-W
03690
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | 4.76%105.79M | 35.47%185.93M | 48.60%100.98M | 20.73%137.25M | 41.68%67.95M | 314.25%113.68M | 157.63%47.96M | -137.88%-53.06M | -169.91%-83.23M | 9.74%140.07M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | -85.90%-5.87M | -82.03%-11.89M | -109.08%-3.16M | -55.04%-6.53M | -482.63%-1.51M | -240.58%-4.21M | 66.54%-259K | 50.76%-1.24M | 11.95%-774K | -108.29%-2.51M |
Impairment and provisions: | -402.50%-121K | 171.30%16.16M | -96.41%40K | 270.37%5.96M | 129.72%1.12M | -136.45%-3.5M | -396.13%-3.75M | 109.04%9.6M | -55.15%1.27M | 42.02%4.59M |
-Impairment of trade receivables (reversal) | -402.50%-121K | 171.30%16.16M | -96.41%40K | 270.37%5.96M | 129.72%1.12M | -136.45%-3.5M | -396.13%-3.75M | 109.04%9.6M | -55.15%1.27M | 42.02%4.59M |
Revaluation surplus: | 63.37%-2.06M | -16.94%-4.81M | -75.82%-5.64M | -18.08%-4.12M | 8.45%-3.21M | -31.61%-3.49M | -607.27%-3.5M | 20.60%-2.65M | 72.83%-495K | 31.49%-3.34M |
-Other fair value changes | 63.37%-2.06M | -16.94%-4.81M | -75.82%-5.64M | -18.08%-4.12M | 8.45%-3.21M | -31.61%-3.49M | -607.27%-3.5M | 20.60%-2.65M | 72.83%-495K | 31.49%-3.34M |
Asset sale loss (gain): | 112.00%53K | 728.57%58K | 257.14%25K | -99.77%7K | -99.77%7K | -45.20%3.06M | --3.06M | 1,565.67%5.58M | ---- | -62.49%335K |
-Loss (gain) on sale of property, machinery and equipment | 112.00%53K | 728.57%58K | 257.14%25K | -99.77%7K | -99.77%7K | -45.20%3.06M | --3.06M | 1,565.67%5.58M | ---- | -62.49%335K |
Depreciation and amortization: | -6.96%18.53M | 20.00%38.9M | 35.01%19.91M | 4.34%32.42M | -11.94%14.75M | -18.56%31.07M | -11.36%16.75M | 8.98%38.15M | 19.32%18.9M | 31.39%35.01M |
-Amortization of intangible assets | -62.50%27K | -45.28%116K | -44.62%72K | -18.46%212K | -0.76%130K | -41.83%260K | -54.04%131K | -26.36%447K | -5.32%285K | -8.03%607K |
Financial expense | -46.83%109K | -36.01%414K | -38.81%205K | -21.19%647K | -16.46%335K | -15.53%821K | -9.48%401K | 19.26%972K | 77.91%443K | 86.93%815K |
Unrealized exchange loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | 104.32%8K | ---- | 89.72%-185K | 87.32%-506K |
Special items | -61.04%967K | -15.74%3.87M | 66.24%2.48M | 77.50%4.59M | -25.87%1.49M | -75.83%2.59M | -77.54%2.01M | -29.71%10.7M | 69.32%8.97M | -79.88%15.23M |
Operating profit before the change of operating capital | 2.21%117.39M | 34.31%228.64M | 41.90%114.86M | 21.57%170.23M | 29.13%80.94M | 1,637.50%140.03M | 213.74%62.68M | -95.75%8.06M | -139.71%-55.11M | -15.50%189.69M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | 40.14%24.41M | -2,150.00%-11.61M | 84.31%17.42M | -104.83%-516K | -71.24%9.45M | -51.34%10.67M | -8.41%32.86M | 163.36%21.94M | 0.24%35.88M | 120.50%8.33M |
Accounts receivable (increase)decrease | 59.50%29.81M | -59.99%-33.45M | 151.74%18.69M | -76.39%-20.91M | -222.39%-36.12M | -120.56%-11.85M | -57.51%29.51M | 620.89%57.64M | 335.00%69.46M | 112.76%8M |
Accounts payable increase (decrease) | -20.48%-34.9M | -64.76%5.93M | -40.74%-28.97M | 152.05%16.82M | -6.27%-20.58M | 137.83%6.67M | 36.03%-19.37M | -85.43%-17.64M | 36.85%-30.28M | -167.92%-9.52M |
prepayments (increase)decrease | 186.78%12.74M | -191.10%-9.69M | -227.02%-14.68M | 231.63%10.63M | -97.06%-4.49M | -135.96%-8.08M | -116.01%-2.28M | 327.91%22.47M | 205.53%14.23M | -137.90%-9.86M |
Special items for working capital changes | 226.55%3.45M | 130.40%1.06M | -53.67%-2.72M | -221.85%-3.5M | 15.34%-1.77M | 45.10%2.87M | -391.50%-2.09M | 129.74%1.98M | 116.66%718K | -60.54%-6.65M |
Cash from business operations | 46.18%152.89M | 4.70%180.88M | 281.34%104.59M | 23.13%172.77M | -72.93%27.43M | 48.58%140.31M | 190.28%101.31M | -47.53%94.44M | -55.97%34.9M | 14.60%179.99M |
Other taxs | -227.23%-16.59M | 35.98%-6.9M | -59.97%-5.07M | -6.81%-10.77M | 32.38%-3.17M | -15.41%-10.09M | 30.07%-4.69M | 20.08%-8.74M | 11.73%-6.7M | 55.58%-10.94M |
Interest received - operating | 85.90%5.87M | 82.03%11.89M | 109.08%3.16M | 1,001.52%6.53M | 482.63%1.51M | -52.06%593K | -66.54%259K | -50.76%1.24M | -11.95%774K | 108.29%2.51M |
Net cash from operations | 38.46%142.16M | 10.30%185.88M | 298.48%102.67M | 28.83%168.52M | -73.41%25.77M | 50.48%130.82M | 234.41%96.88M | -49.33%86.93M | -60.06%28.97M | 28.37%171.57M |
Cash flow from investment activities | ||||||||||
Decrease in deposits (increase) | --101.5M | ---101.5M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 200.00%25M |
Sale of fixed assets | 394.69%2.14M | 7,454.41%5.14M | --433K | -94.55%68K | ---- | 4,200.00%1.25M | --35K | 314.29%29K | ---- | -85.71%7K |
Purchase of fixed assets | -62.67%-15.97M | -31.06%-29.58M | -6.14%-9.82M | 27.60%-22.57M | 57.11%-9.25M | 29.83%-31.17M | -2.04%-21.57M | 62.64%-44.42M | 67.73%-21.14M | -18.40%-118.91M |
Purchase of intangible assets | ---- | ---- | ---- | ---228K | ---228K | ---- | ---- | ---- | ---- | 77.57%-109K |
Recovery of cash from investments | -99.52%2.06M | 175.31%1.31B | 37.20%428.64M | 70.56%476.12M | 143.52%312.41M | 82.22%279.16M | -2.44%128.29M | -25.17%153.2M | 35.32%131.5M | -73.03%204.74M |
Cash on investment | ---- | -176.69%-1.31B | -36.80%-423M | -87.82%-472M | -197.31%-309.2M | -46.70%-251.3M | 44.09%-104M | -31.77%-171.3M | -43.08%-186M | 82.45%-130M |
Net cash from investment operations | 2,491.58%89.73M | -550.84%-121.13M | 40.21%-3.75M | -799.52%-18.61M | -328.10%-6.28M | 96.69%-2.07M | 103.64%2.75M | -224.23%-62.5M | 23.08%-75.64M | 82.05%-19.28M |
Net cash before financing | 134.42%231.89M | -56.81%64.75M | 407.52%98.92M | 16.44%149.91M | -80.44%19.49M | 426.83%128.75M | 313.48%99.64M | -83.95%24.44M | -80.98%-46.67M | 480.16%152.29M |
Cash flow from financing activities | ||||||||||
Refund | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 60.56%-69.57M |
Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.78%1.31M |
Interest paid - financing | 46.83%-109K | 36.01%-414K | 38.81%-205K | 21.19%-647K | 16.46%-335K | 15.53%-821K | 9.48%-401K | -19.26%-972K | -207.64%-443K | -168.09%-815K |
Dividends paid - financing | ---70.52M | ---- | ---- | ---- | ---- | ---35.02M | ---- | ---- | ---- | 65.43%-84.62M |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---17.8M | ---6.82M | ---- | ---- | ---- | ---- | -8.55%-46.71M |
Net cash from financing operations | -2,163.09%-73.89M | 71.72%-7.09M | 68.13%-3.27M | 39.70%-25.06M | -250.77%-10.25M | -437.35%-41.56M | 19.15%-2.92M | 96.22%-7.74M | 97.67%-3.61M | -158.33%-204.61M |
Effect of rate | -81.35%641K | -85.92%1.47M | -39.41%3.44M | 295.99%10.47M | 402.88%5.67M | 49.48%-5.34M | -148.80%-1.87M | -293.84%-10.58M | 94.82%3.84M | 599.49%5.46M |
Net Cash | 65.18%158M | -53.82%57.66M | 934.68%95.66M | 43.20%124.85M | -90.44%9.25M | 421.96%87.18M | 292.33%96.71M | 131.92%16.7M | 72.22%-50.29M | -113.88%-52.32M |
Begining period cash | 7.57%840.47M | 20.95%781.34M | 20.95%781.34M | 14.51%646.02M | 14.51%646.02M | 1.10%564.18M | 1.10%564.18M | -7.75%558.05M | -7.75%558.05M | 166.34%604.91M |
Cash at the end | 13.48%999.12M | 7.57%840.47M | 33.21%880.43M | 20.95%781.34M | 0.29%660.93M | 14.51%646.02M | 28.81%659.02M | 1.10%564.18M | 20.12%511.6M | -7.75%558.05M |
Cash balance analysis | ||||||||||
Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | --659.02M | ---- | ---- | ---- |
Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | --659.02M | ---- | ---- | ---- |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.